An alternative hypothesis posits that the etiology may involve a breakdown in immune regulation, marked by increased expression of the interleukin (IL)-6 gene—a cytokine with wide-ranging impacts on the immune system and hematopoiesis, closely associated with the development of multiple myeloma [7, 10]. This evidence concerns the gene IL6 and plasma cell myeloma.